Symposium Co-hosted by the JPMA and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Report on the Symposium: “Recommendations for the G7 Hiroshima Summit Health Agenda” ~Harnessing Lessons from COVID-19 to Advance Progress Toward SDG 3: A Roadmap for Action~
The JPMA and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) co-hosted the symposium “Recommendations for the G7 Hiroshima Summit Health Agenda ~Leveraging Lessons from COVID-19 to Promote Progress Toward SDG 3:A Roadmap for Action~” on Friday, May 12, 2023, from 4:30 p.m. to 6:30 p.m.
We invited leaders shaping health policies and systems in Japan and internationally to engage in in-depth discussions on global health challenges and solutions for the post-COVID era, with the aim of widely disseminating the outcomes of these discussions.
This symposium is also featured on the website of IFPMA, one of the co-organizers.
Proposals for the G7 Hiroshima Summit Health Agenda - IFPMA
Program
Summary of Proceedings
Sponsored Content
“G7 Hiroshima Summit: Recommendations for the Health Agenda”
Newspaper and Magazine Ads | JPMA Video Content and Ads | Japan Pharmaceutical Manufacturers Association (jpma.or.jp)
A report on this symposium was published in the June 16, 2023, morning edition of the Yomiuri Shimbun (Tokyo edition).
Subsequently, throughout June, reports were published in the morning editions of the Yomiuri Shimbun’s Osaka, Nagasaki, and Hiroshima editions.